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ABSTRACT 24 
Nitric oxide influences intramuscular signaling that affects skeletal muscle glucose uptake during 25 
exercise. The role of the main NO-producing enzyme isoform activated during skeletal muscle 26 
contraction, neuronal nitric oxide synthase mu (nNOSμ), in modulating glucose uptake has not 27 
been investigated in a physiological exercise model. In this study, conscious and unrestrained 28 
chronically catheterized nNOSμ+/+ and nNOSμ-/- mice either remained at rest or ran on a 29 
treadmill at 17 m/min for 30 min. Both groups of mice demonstrated similar exercise capacity 30 
during a maximal exercise test to exhaustion (17.7±0.6 vs 15.9±0.9 min for nNOSμ+/+ and 31 
nNOSμ-/- respectively, P > 0.05). Resting and exercise blood glucose levels were comparable 32 
between genotypes. Very low levels of NOS activity were detected in skeletal muscle from 33 
nNOSμ-/- mice and exercise increased NOS activity only in nNOSμ+/+ mice (4.4±0.3 to 5.2±0.4 34 
pmol/mg/min, P < 0.05). Exercise significantly increased glucose uptake in gastrocnemius 35 
muscle (5 to 7-fold) and surprisingly, more so in nNOSμ-/- than nNOSμ+/+ mice (P < 0.05). This 36 
is in parallel with a greater increase in AMPK phosphorylation during exercise in nNOSμ-/- mice. 37 
In conclusion, nNOSμ is not essential for skeletal muscle glucose uptake during exercise and the 38 
higher skeletal muscle glucose uptake during exercise in nNOSμ-/- mice may be due to 39 
compensatory increases in AMPK activation. 40 
 41 
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INTRODUCTION 43 
Skeletal muscle glucose uptake during exercise is an important physiological process for 44 
blood glucose and cellular energy homeostasis. It is regulated by intramuscular signaling that 45 
modulates membrane permeability to glucose (42). Nitric oxide (NO) is a signaling mediator that 46 
can alter membrane permeability to glucose via modulation of GLUT4 translocation (7, 43). The 47 
production of NO increases with skeletal muscle contraction/ exercise (4, 27, 45) and a series of 48 
studies using NOS inhibitors show that NO mediates skeletal muscle glucose uptake during 49 
contraction/ exercise (3, 5, 23, 35, 43, 45). In contrast, some studies found that NO does not play 50 
a role in muscle glucose uptake during contraction (7, 12, 21, 46).  Methodology differences are 51 
believed to contribute to some of the conflicting results (32).  52 
In skeletal muscle, NO from contraction may be derived from several NOS isoforms 53 
including endothelial NOS (eNOS) and neuronal NOS (nNOS), which are constitutively 54 
expressed in skeletal muscle of rodents (24, 25). Inducible NOS (iNOS) is expressed under 55 
inflammatory or disease states (1, 9) and therefore is not likely to be involved in acute 56 
contraction-mediated events of animals/ healthy subjects. The most commonly used NOS 57 
inhibitors in studies investigating the role of NO in contraction-stimulated glucose uptake, N-G-58 
Monomethyl-L-arginine (L-NMMA) and N-G-Nitro-L-Arginine Methyl Ester (L-NAME), are 59 
non-specific competitive inhibitors that inhibit all of the NOS isoforms (54). Therefore, these 60 
NOS inhibitors cannot isolate the role of different NOS isoforms in skeletal muscle glucose 61 
uptake during contraction/ exercise. As such, genetically modified rodent models are imperative 62 
in this regard.  63 
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Skeletal muscle glucose uptake during treadmill exercise has previously been determined 64 
in eNOS-/- mice which were found to have higher glucose uptake compared with wild type 65 
controls (28). This was postulated to be due to the exercise-induced hypoxia in contracting 66 
muscle which, in turn, may have stimulated a greater muscle glucose uptake (28) since hypoxia 67 
is a potent stimulator of skeletal muscle glucose uptake (6). In addition, NO production during ex 68 
vivo contraction was not different between eNOS+/+ and eNOS-/- muscles (13) suggesting that 69 
eNOS may not be directly involved in NO-mediated intramuscular signaling. Given that nNOSμ 70 
is the major NOS isoform activated during contraction (27), it was surprising to find that nNOSμ 71 
knockout muscles did not have attenuated muscle glucose uptake during ex vivo contraction 72 
(16). Nevertheless, NOS inhibition of isolated nNOSμ knockout (nNOSμ-/-) and wild type 73 
(nNOSμ+/+) muscles still attenuated the increase in muscle glucose uptake (16) suggesting that 74 
NO was still playing a role in muscle glucose uptake during contraction. It should be considered 75 
that ex vivo contraction lacks the complex integrated interactions underlying in vivo exercise 76 
conditions such as neural input, blood flow and hormonal changes. Highly relevant to this 77 
context is that nNOS has been shown to mediate arterial relaxation in contracting skeletal muscle 78 
(27). Thus, in vivo studies are essential to define the role of nNOSμ in muscle glucose uptake 79 
during exercise. 80 
In this study, nNOSμ+/+ and nNOSμ-/- mice were used to investigate the effect of nNOSμ 81 
on skeletal muscle glucose uptake in conscious and unrestrained chronically catheterized mice 82 
running on a treadmill. This allows examination of the role of nNOSμ in skeletal muscle glucose 83 
uptake in a physiological unstressed condition with intact hemodynamic and intramuscular 84 
signaling responses. We hypothesized that the increase in muscle glucose uptake during 85 
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treadmill running would be attenuated in nNOSμ-/- mice because nNOSμ is the major NOS 86 
isoform activated during contraction (27).        87 
 88 
MATERIALS AND METHODS 89 
Animals 90 
All procedures were approved by The Alfred Medical Research and Education Precinct 91 
(AMREP) Animal Ethics Committee, and conformed to the Australian Code of Practice for the 92 
Care and Use of Animals for Scientific Purposes (2004, 7th Edition). nNOSμ+/+ and nNOSμ-/- 93 
littermates were generated by mating C57Bl/6 nNOSμ+/- mice originally obtained from Jackson 94 
Laboratories (Bar Harbor, ME). Genotyping was performed using tail samples obtained at day 21 95 
of age by a commercial vendor (Transnetyx Inc., Cordova, TN). Mice were housed in standard 96 
cages and maintained under constant temperature of 21 ± 1oC with 12-hour light/ dark cycle in 97 
the AMREP Animal Facility. Animals had access to standard rodent chow and water ad libitum. 98 
Both male and female mice were used for experiments at 16 weeks of age.  99 
 100 
Exercise stress test 101 
Mice were subjected to an incremental exercise stress test as previously described (29) to 102 
determine their maximum exercise capacity. Briefly, two days following a familiarization test 103 
(10 m/min for 10 min) mice commenced running at a speed of 10 m/min on a 0% incline 104 
treadmill. Running speed was increased by 4 m/min every 3 min until mice were exhausted, 105 
which was defined as the point whereby mice continuously remained at the back of the treadmill 106 
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for more than five seconds despite tail prodding. Treadmill electrical stimulation was not used in 107 
any of the tests. 108 
 109 
Surgery and experimental procedures 110 
Surgery procedures were performed as previously described (2) except that only jugular 111 
vein cannulation was performed due to an observed intolerance of nNOSμ-/- mice to chronic 112 
carotid cannulation. Briefly, mice were anaesthetized with 5% isoflurane in oxygen and 113 
maintained with 2% isoflurane in oxygen throughout the cannulation procedure. Carprofen was 114 
given subcutaneously for pain relief prior to the skin incision. The right jugular vein was 115 
cannulated with a silastic catheter. The free end of the catheter was tunneled under the skin to the 116 
back of the neck where it was exteriorized. The catheter was kept patent with saline containing 117 
200 U/ml of heparin and 5 mg/ml of ampicillin, and sealed with stainless steel plugs. Mice were 118 
housed individually after surgery and body weight was monitored. Mice were used for 119 
experiments at least three days post-surgery when they had fully recovered as indicated by 120 
normal activity, healthy appearance and weight regained after surgery.  121 
On the day of the experiment, the exteriorized jugular catheter was connected, via a 122 
stainless steel connector, with Micro-Renathane tubing approximately one hour prior to the 123 
experiment. Mice were then placed in a single lane treadmill to acclimate to the environment. 124 
During the experiment, mice remained sedentary or began a single bout of exercise (t = 0 min). 125 
Exercise started at 15 m/min (0% incline) for three min and then increased to 17 m/min 126 
throughout the rest of the experiment until t = 30 min (28, 46). Sedentary mice were allowed to 127 
move freely on the stationary treadmill for 30 min. In all mice, a bolus of 13 µCi of [1,2-3H]2-128 
7 
 
deoxy-glucose ([3H]2-DG) was injected into the jugular vein at t = 5 min for evaluation of tissue-129 
specific glucose uptake. At the end of the experiment, mice were anaesthetized with a jugular 130 
vein injection of sodium pentobarbital (3 mg). A tail blood sample was immediately obtained for 131 
determination of blood glucose levels. The gastrocnemius and superficial vastus lateralis muscles 132 
from each limb and the brain were rapidly excised, frozen with liquid nitrogen-cooled tongs and 133 
stored at -80oC. A blood sample was collected via cardiac puncture after exercise and used for 134 
plasma insulin and lactate determination.   135 
 136 
Muscle glucose uptake determination 137 
The determination of muscle glucose uptake was performed as previously described (8). 138 
Muscle sample and brain tissue (~30 mg) were homogenized with 1.5 ml of MilliQ water. 139 
Phosphorylated [3H]2-DG ([3H]2-DG-6-P) was extracted from an aliquot of centrifuged  140 
homogenates (6000 rpm for 10 min at 4oC) using an anion exchange resin column (AG1-X8, 141 
Bio-Rad). Radioactivity of the samples was determined using a β-counter (Tri-Carb 2800TR; 142 
Perkin Elmer, Chicago, IL, USA). Glucose uptake for each muscle was expressed as an index of 143 
[3H]2-DG-6-P accumulation in the muscle normalized to [3H]2-DG-6-P in the brain of that 144 
mouse, as done previously (8, 11). Brain glucose uptake was used as a control for the integrated 145 
plasma [3H]2-DG concentration differences over the duration of the experiments (8) as glucose 146 
uptake into the brain except the hypothalamus occurs via passive diffusion that follows glucose 147 
concentration gradient between the blood and brain tissue (31). In addition, intracellular glucose 148 
phosphorylation under normoglycaemic condition and hexokinase II have no impact on brain 149 
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glucose uptake (14, 40). Importantly, [3H]2-DG-6-P in the brain was not different between 150 
genotypes.   151 
 152 
Blood and plasma biochemistry 153 
Plasma insulin concentrations were determined using an enzyme-linked immunosorbent 154 
assay (Mercodia, AB, Uppsala, Sweden) as per manufacturer’s instructions. Plasma lactate 155 
concentrations were analyzed with the enzymatic method of Lowry and Passonneau (30). Blood 156 
glucose levels were determined directly from the tail blood using an ACCU-CHEK Advantage 157 
monitor (Roche Diagnostics, Indianapolis, Indiana, US). 158 
 159 
Immunoblotting 160 
Immunoblotting was performed using ground frozen gastrocnemius muscle homogenized 161 
with 200 times volume of solubilizing buffer (125 mM Tris-HCl [pH 6.8], 4% SDS, 10% 162 
glycerol, 10 mM EGTA, 0.1 M DTT and 0.01% bromophenol blue) as described previously (15, 163 
38). Five µg of total protein from whole homogenates were separated on SDS-PAGE gels (Bio-164 
Rad Laboratories, Hercules, CA), which was then wet transferred onto polyvinylidine fluoride 165 
(PVDF) membranes. Following membrane blocking with 5% skim milk in TBS solution, they 166 
were probed with the following primary antibodies overnight: phospho-AMPKα Thr172 (1:1000), 167 
phospho-TBC1D1 Ser660 (1:1000), AMPKα (1:1000), TBC1D1 (1:500), α-tubulin (1:1000) (Cell 168 
Signaling Technology, Danvers, MA, USA); nNOS (1:10,000), eNOS (1:10,000), iNOS (1:2000) 169 
(BD Biosciences, San Jose, California, USA); GLUT4 (1:8000) (Thermo Scientific, Rockford, 170 
IL, USA), and actin (1:40,000) (Sigma Aldrich, St Louis, MO, USA). Chemiluminescent signal 171 
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was developed with ECL substrate (SuperSignal West Femto, Pierce, MA, USA) and it was 172 
captured with a charge-coupled device (CCD) camera using Quantity One software (Bio-Rad). 173 
Pre-stained molecular weight markers were immediately imaged under white light source 174 
without changing the membrane position. To quantify both phosphorylated and total protein 175 
abundance, phosphorylation-specific primary antibody signal was first determined and then 176 
stripped (62.5 mM Tris-HCl pH 6.8, 2% SDS, 0.8% β-mercaptoethanol), re-blocked and re-177 
probed with primary antibody against the total protein. Loading control proteins were always 178 
probed on non-stripped membranes and actin was used for all proteins except GLUT4. Actin and 179 
GLUT4 have similar molecular weights and it was not possible to probe both of these proteins 180 
without undertaking the stripping process, therefore α-tubulin was used as a loading control for 181 
GLUT4 abundance.  182 
 183 
NOS activity assay 184 
NOS activity was determined as described previously (29) using radiolabeled L-185 
[14C]arginine. NOS activity was expressed as picomoles of L-[14C]citrulline formed per min, per 186 
mg of protein. It was determined based on the difference between samples incubated with and 187 
without L-NAME. 188 
  189 
Statistical analysis 190 
All data are expressed as means ± SEM. Statistical analysis was performed using SPSS 191 
statistical package using one factor ANOVA (genotype) or two-factor ANOVA (genotype and 192 
exercise). If there was a significant interaction, specific differences between mean values were 193 
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identified using Fisher’s least significance test. The significance level was set at P < 0.05. No 194 
sex-specific differences were observed in muscle glucose uptake during exercise (male vs 195 
female: nNOSμ+/+: 1.72±0.23 vs 1.50±0.14, p > 0.05; nNOSμ-/-: 1.72±0.10 vs 2.10±0.17, p > 196 
0.05) and therefore, data from male and female mice were pooled and analyzed together.   197 
 198 
RESULTS 199 
Body weight and exercise capacity of nNOSμ+/+ and nNOSμ-/- mice 200 
At 16 weeks of age, the body weight of nNOSμ-/- mice was significantly (P < 0.05) lower 201 
than that of nNOSμ+/+ littermates (Table 1). The ratio of male to female mice was not 202 
significantly different in either genotype (Table 1). The maximum running speed achieved 203 
during the exercise stress test was similar between genotypes (Table 1). Similarly, the maximum 204 
running times were not different between these mice although nNOSμ-/- mice tended (P = 0.10) 205 
to run for a shorter time than nNOSμ+/+ littermates (Table 1).  206 
 207 
Blood glucose level 208 
At the end of the experiment, blood glucose concentration from the sedentary mice was 209 
not significantly different between genotypes (7.9 ± 0.5 mmol/l vs 7.3 ± 0.8 mmol/l for 210 
nNOSμ+/+ and nNOSμ-/- respectively, P > 0.05). Exercise had no effect on the blood glucose 211 
concentration compared with the sedentary state and remained similar between genotypes (8.7 ± 212 
1.0 mmol/l vs 7.1 ± 0.3 mmol/l for nNOSμ+/+ and nNOSμ-/- respectively, P > 0.05).     213 
 214 
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Skeletal muscle glucose uptake 215 
Gastrocnemius muscle glucose uptake at rest (sedentary state) was not different between 216 
genotypes (Fig. 1A). Exercise significantly increased glucose uptake in gastrocnemius muscle (5 217 
to ~7-fold) and the exercise-induced glucose uptake (fold-increase) was significantly higher in 218 
nNOSμ-/- compared with nNOSμ+/+ mice (P < 0.05) (Fig 1B). A similar muscle glucose uptake 219 
pattern was observed in the superficial vastus lateralis (SVL) muscle (Fig 1C & 1D). 220 
 221 
Plasma insulin and lactate levels 222 
At the end of the exercise, plasma insulin was not different between genotypes (1.00 ± 223 
0.16 vs 0.89 ± 0.17 µg/l for nNOSμ+/+ and nNOSμ-/- respectively, P > 0.05). Plasma lactate was 224 
significantly elevated following exercise compared with the sedentary state (main effect, P < 225 
0.05), and the increases following exercise were similar across genotypes (6.0 ± 0.5 vs 5.4 ± 0.7 226 
mmol/l for nNOSμ+/+ and nNOSμ-/- respectively, P > 0.05).  227 
 228 
Protein expression and phosphorylation  229 
The expression of actin and α-tubulin proteins was not different between genotypes and 230 
they were used as loading controls. Total AMPKα expression in gastrocnemius muscle was not 231 
different between genotypes (Fig 2A and 2B). For sedentary muscles, AMPKα Thr172 232 
phosphorylation relative to AMPKα abundance was also not different between genotypes. 233 
Exercise significantly increased skeletal muscle AMPKα Thr172 phosphorylation of both nNOSμ-234 
/- and nNOSμ+/+ mice compared with their respective sedentary group (Fig 2C). The increase in 235 
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AMPKα Thr172 phosphorylation was significantly greater in nNOSμ-/- mice compared with 236 
nNOSμ+/+ mice (Fig 2C). Expression of TBC1D1 in gastrocnemius muscle was also similar 237 
between genotypes (Fig 3A and 3B) and there was no difference in sedentary TBC1D1 Ser660 238 
phosphorylation relative to TBC1D1 abundance between genotypes (Fig 3C). Exercise increased 239 
TBC1D1 Ser660 phosphorylation (Fig 3C; main effect, P < 0.05). There was no iNOS detected in 240 
either nNOSμ+/+ or nNOSμ-/- skeletal muscle. Endothelial NOS (eNOS) (Fig 4A) and GLUT4 241 
(Fig 4B) protein expressions were not different between genotypes.   242 
 243 
Expression of nNOSμ, nNOS splice variants and NOS activity  244 
Neuronal NOSμ and nNOSβ (which are splice variants of nNOS) were detected in 245 
gastrocnemius muscles of nNOSμ+/+ but not nNOSμ-/- mice (results not shown), as we have 246 
previously reported in EDL muscles (16). Exercise caused a significant increase in NOS activity 247 
in gastrocnemius muscles from nNOSμ+/+ mice (P < 0.05). Low levels of NOS activity were 248 
detected in gastrocnemius muscle from nNOSμ-/- mice (Fig 5) which is in accordance with 249 
previous data from EDL muscles (16) and brain tissues of nNOSμ-/- mice (18). 250 
 251 
DISCUSSION 252 
In this study we observed that skeletal muscle glucose uptake increased to a significantly 253 
greater extent during 30-min of moderate intensity treadmill running in nNOSμ-/- mice than 254 
nNOSμ+/+ littermates. The higher muscle glucose uptake in nNOSμ-/- mice was observed together 255 
with a greater increase in skeletal muscle AMPK phosphorylation during exercise in nNOSμ-/- 256 
mice.    257 
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Given that NO is involved in GLUT4 translocation and nNOSμ is the main NOS isoform 258 
that produces NO during contraction in skeletal muscle (27), it is surprising and interesting to 259 
find that glucose uptake during physiological in vivo exercise was enhanced instead of 260 
attenuated in mice genetically lacking nNOSμ. Nevertheless, it was recently reported that 261 
although NO is involved in mediating skeletal muscle glucose uptake during ex vivo contraction, 262 
nNOSμ is not essential in this process (16). Skeletal muscle glucose uptake during ex vivo 263 
contraction was normal in mice with or without nNOSμ however glucose uptake was attenuated 264 
by NOS inhibition (L-NMMA) in both groups. The reduction in glucose uptake during 265 
contraction with L-NMMA was reversed by L-arginine indicating a critical role of NO in 266 
mediating glucose uptake in skeletal muscle during ex vivo contraction (16). Under 267 
physiological in vivo exercise conditions, various factors beyond the signaling events within the 268 
muscle including endocrine, vascular, neural and internal milieu inputs that work in an integrated 269 
fashion could affect skeletal muscle glucose uptake.  270 
Neuronal NOSμ-/- mice used in this study were generally comparable with their nNOSμ+/+ 271 
littermates in a number of phenotypic features that may directly or indirectly influence muscle 272 
glucose uptake. The blood glucose level at rest (sedentary) and during exercise was similar in 273 
both genotypes implying that the higher glucose uptake in nNOSμ-/- mice was not due to higher 274 
blood glucose levels (17). Similarly, plasma insulin levels after exercise were not different 275 
between genotypes suggesting that the observed higher glucose uptake in nNOSμ-/- mice was not 276 
due to a potential additive effect of insulin on contraction-stimulated glucose uptake (57).  277 
Exercise stimulated a greater muscle AMPK phosphorylation in nNOSμ-/- mice compared 278 
with nNOSμ+/+ littermates. AMPK is a metabolic fuel sensor that can be activated following 279 
metabolic stress/ perturbations in which the degradation of ATP and the consequent 280 
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accumulation of ADP and AMP increase the ADP/ATP and AMP/ ATP ratio which leads to an 281 
increase in phosphorylation of AMPK (51). The higher AMPK phosphorylation in nNOSμ-/- 282 
mice suggests that they may have endured a higher metabolic stress. However, both groups of 283 
mice had similar maximum exercise capacity (maximal running speed and time) which suggests 284 
that the metabolic stress levels may have been similar. Although not statistically significant, it is 285 
possible that the 10% longer running time in the control mice compared with the nNOSμ-/- mice 286 
could be important during high intensity exercise. We unfortunately did not measure oxygen 287 
uptake or carbohydrate oxidation during this study. Alternatively, AMPK can also be activated 288 
under hypoxic conditions (10, 56). nNOS has been shown to be involved in mediating arteriolar 289 
relaxation in contracting muscles (27, 50). Therefore, it is plausible that nNOSμ-/- mice might 290 
have attenuated blood flow during exercise causing some degree of muscle hypoxia and a higher 291 
intramuscular metabolic stress (48) leading to a subsequent increase in phosphorylation of 292 
AMPK. It is unfortunate that we were unable to measure blood flow in these mice during 293 
exercise due to intolerance of the nNOSμ-/- mice to chronic carotid artery catheterisation.  294 
However, eNOS-/- mice with lower exercise-induced increases in blood flow to the contracting 295 
muscle and a likely greater hypoxic state in the muscles have no greater increase in AMPK 296 
phosphorylation during exercise (28). Indeed, we have shown previously that there is little effect 297 
of hypoxia on glucose uptake during exercise in humans (56). Therefore, hypoxia-induced 298 
increases in AMPK phosphorylation in nNOSμ-/- mice during exercise appear to be an unlikely 299 
stimulus for the greater increase in AMPK phosphorylation during exercise and thus the reasons 300 
for this finding remain unclear.  301 
Though the higher muscle glucose uptake in nNOSμ-/- mice could be due to the increased 302 
AMPK phosphorylation, we have no direct evidence to prove a causal relationship between these 303 
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parameters in nNOSμ-/- mice as we have not investigated glucose uptake during exercise in these 304 
mice while preventing the increase of AMPK activation. It may be worthwhile to compare 305 
skeletal muscle glucose uptake during ex vivo contraction in nNOSμ-/- muscles that are crossed 306 
with an AMPK dominant negative mouse strain. 307 
TBC1D1 has been implicated in the regulation of muscle glucose uptake during 308 
contraction/ exercise in which glucose uptake is decreased in muscle overexpressing TBC1D1 309 
mutated on several predicted AMPK phosphorylation sites (53). TBC1D1 Ser660 phosphorylation 310 
is one of the downstream effectors of AMPK (53) that is stimulated during contraction in mice 311 
(53) and exercise in humans (22). The increase in TBC1D1 Ser660 phosphorylation with exercise 312 
in nNOSμ-/- mice suggests that an AMPK-TBC1D1 mechanism may potentially be involved in 313 
stimulating the higher glucose uptake in these mice which, however, remained to be investigated. 314 
AMPK can also phosphorylate other downstream mediators such as AS160 to stimulate muscle 315 
glucose uptake (26) although there is evidence that AMPK-mediated AS160 phosphorylation 316 
does not have a role in muscle glucose uptake during contraction (52).        317 
A caveat to the interpretation of the data using genetically-modified mice needs to be 318 
considered. The loss of a protein of interest during development that spans the entire lifespan 319 
could possibly induce secondary adaptations including compensatory overexpression of closely 320 
related proteins (33). These changes could mask the effects elicited by the loss of the protein of 321 
interest. In this study, no compensatory increase in iNOS, eNOS, nNOS splice variants, or 322 
GLUT4, all of which could directly or indirectly affect muscle glucose uptake, were detected in 323 
nNOSμ-/- mice. Likewise, there was no difference in total AMPK or TBC1D1 expression 324 
between genotypes. These data suggest that nNOSμ, similar to ex vivo contraction (16), may not 325 
play a role in muscle glucose uptake during in vivo exercise because total loss of nNOSμ did not 326 
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attenuate glucose uptake nor elicit a compensatory response in the proteins examined. It should 327 
be considered, however, that there may have been compensatory increases in the other potential 328 
proteins that may regulate skeletal muscle glucose uptake including Ca2+/ calmodulin-dependent 329 
protein kinase (CaMKII) (58), protein kinase C (20), and Rac1/PAK1 (49). 330 
In addition, an exacerbated ROS accumulation during exercise in nNOSμ-/- mice may 331 
have contributed to the higher muscle glucose uptake. Muscle contraction/ exercise increases 332 
ROS production in the heart and skeletal muscles (41, 47), and ROS increases muscle glucose 333 
uptake during ex vivo contraction (36, 47). Following acute exercise, there is significantly higher 334 
accumulation of ROS in the myocytes from mice lacking nNOS compared with controls (44). If 335 
a similar effect is conferred by nNOS in skeletal muscle during exercise as in the myocytes, it is 336 
plausible that muscle glucose uptake in nNOSμ-/- mice could be increased as a result of ROS-337 
induced glucose uptake. Nevertheless, some studies have shown that ROS has no stimulatory 338 
effect on muscle glucose uptake during in vivo conditions in rats (34) and humans (37).  339 
The relative roles of nNOSμ could also be affected by the exercise intensity. Given that it 340 
has been shown that nNOS is expressed at higher levels in fast-twitch muscles than slow-twitch 341 
muscles (24, 36) it would be expected that nNOS would have a greater contribution to glucose 342 
uptake during exercise in fast-twitch muscles and/ or at higher exercise intensities. In fact, we 343 
have shown that NOS inhibition significantly attenuates the increase in glucose uptake during ex 344 
vivo contraction in EDL (mainly fast-twitch) but not in soleus muscles (mainly slow-twitch) 345 
(36). However, the fiber type effects on muscle glucose uptake during in vivo exercise are 346 
unclear. It is possible that there was no effect of a lack of nNOSμ on glucose uptake during 347 
exercise because the intensity of exercise was insufficient to substantially activate nNOSμ. 348 
However, the observed increase in NOS activity during exercise suggests that nNOSμ was 349 
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indeed activated. Further studies should examine the effects of nNOSμ on glucose uptake during 350 
exercise at different intensities. 351 
 In this study, we observed very low levels of NOS activity in nNOSμ-/- mice while eNOS 352 
abundance was not different between the genotypes. Together with the previous finding that 353 
NOS activity is normal or increased in eNOS+/- and eNOS-/- mice, respectively (28), these data 354 
indicate that nNOSμ is the predominant NOS isoform responsible for NOS activity in skeletal 355 
muscle. This finding is in agreement with a study showing that nNOS is the predominant NOS 356 
isoform that activates NO downstream signaling via cGMP during ex vivo contraction (27). 357 
Interestingly, eNOS abundance in skeletal muscle was not different between nNOSμ-/- and their 358 
wild type littermate control mice in this study, as opposed to our previous study that found a 359 
compensatory increase of eNOS expression in nNOSμ-/- muscles (55). However, in that study the 360 
control mice were C57Bl/6 mice rather than littermate controls (55). Others have also found no 361 
compensation of eNOS expression in myocytes and uterus of mice lacking nNOS when 362 
comparing to their wild type littermates (19, 39). This highlights the importance of using 363 
littermate controls as a proper experimental control.    364 
In summary, nNOSμ is not essential for skeletal muscle glucose uptake during in vivo 365 
exercise. The greater muscle glucose uptake observed in nNOSμ-/- mice than nNOSμ+/+ mice 366 
during moderate intensity treadmill exercise may be due to the observed greater increase in 367 
AMPK activation during exercise.  368 
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FIGURE LEGENDS 559 
Figure 1: Gastrocnemius muscle glucose uptake normalized to brain glucose uptake of that same 560 
animal (ratio) (A), and relative to sedentary state (fold change) (B), superficial vastus lateralis 561 
(SVL) muscle glucose uptake normalized to brain glucose uptake of that same animal (ratio) (C), 562 
and relative to sedentary state (fold change) (D). Data are means ± SEM, n = 11 & 3 for 563 
sedentary nNOSμ+/+ and nNOSμ-/- respectively, and 10 & 6 for exercise nNOSμ+/+ and nNOSμ-/- 564 
respectively. * P < 0.05 vs sedentary of the same genotype, # P < 0.05 vs exercise nNOSμ+/+.  565 
 566 
Figure 2: Representative blots for AMPK, AMPKα Thr172 phosphorylation and actin (A), 567 
gastrocnemius muscle AMPKα abundance in sedentary muscles (B), and gastrocnemius muscle 568 
AMPKα Thr172 phosphorylation relative to AMPKα abundance (C). Data are means ± SEM, n = 569 
9 & 4 for sedentary nNOSμ+/+ and nNOSμ-/- respectively, and 9 & 5 for exercise nNOSμ+/+ and 570 
nNOSμ-/- respectively.* P < 0.05 vs sedentary of the same genotype; # P < 0.05 vs exercise 571 
nNOSμ+/+. 572 
 573 
Figure 3: Representative blots for TBC1D1, TBC1D1 Ser660 phosphorylation and actin (A), 574 
gastrocnemius muscle TBC1D1 abundance in sedentary muscles (B), gastrocnemius muscle 575 
TBC1D1 Ser660 phosphorylation relative to TBC1D1 abundance (C). Data are means ± SEM, n = 576 
9 & 4 for sedentary nNOSμ+/+ and nNOSμ-/- respectively, and 9 & 5 for exercise nNOSμ+/+ and 577 
nNOSμ-/- respectively. † P < 0.05 main effect for exercise. 578 
  579 
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Figure 4: Gastrocnemius muscles eNOS (A) and GLUT4 (B) protein expressions in sedentary 580 
state relative to actin and tubulin abundance respectively. Data are means ± SEM; n = 9 for 581 
nNOSμ+/+ and 4 for nNOSμ-/-. For GLUT4 protein expression, bands at 45 and 40 kDa 582 
represented glycosylated and de-glycosylated GLUT4 respectively. Both bands were used for 583 
data analysis. 584 
 585 
Figure 5: Gastrocnemius muscle NOS activity at rest (sedentary) and during exercise. Data are 586 
means ± SEM; n = 7 & 3 for sedentary nNOSμ+/+ and nNOSμ-/- respectively; and 7 & 5 for 587 
exercise nNOSμ+/+ and nNOSμ-/- respectively. * P < 0.05 vs sedentary of the same genotype; ‡ P 588 
< 0.05 vs nNOSμ+/+ of the same condition. 589 
590 
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Table 1: Body weight and exercise capacity of nNOSμ+/+ and nNOSμ-/- mice  600 
 nNOSμ+/+ nNOSμ-/- 
Male : female (number) 15 : 15 6 : 8 
Body weight (g) 29.0 ± 0.8 23.6 ± 1.0  ‡ 
Max running speed (m/min) 31.5 ± 0.9 29.4 ± 1.2 
Max running time (min) 17.7 ± 0.6 15.9 ± 0.9  
Values are means ± SEM, n = 30 and 14 for nNOSμ+/+ and nNOSμ-/- respectively. ‡ P < 0.05 vs 601 
nNOSμ+/+. 602 
